← All Sponsors
SPONSOR

MOMA Therapeutics

Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Advanced Solid TumorMetastatic Solid TumorProstate CancerPancreas CancerBreast CancerOvarian CancerHomologous Recombination Deficiency
NCT06545942 Phase 1
Recruiting

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

Advanced Solid Tumor
United States, Spain, United Kingdom View Trial →